Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation

Thorax

Volumn 49, Issue 6, 1994, Pages 567-572

  Llewellyn Jones, C G ^a   Stockley, R A ^a   Lomas, D A ^b  

^a GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

[4 (4 BROMOPHENYLSULFONYLCARBAMOYL)BENZOYL]VALYLPROLINE N (2 METHYL 1 TRIFLUOROACETYLPROPYL)AMIDE; ELASTASE; ELASTASE INHIBITOR; ENZYME INHIBITOR; FIBRONECTIN; PROTEINASE INHIBITOR;

ARTICLE; CELL VIABILITY; CONNECTIVE TISSUE; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG DISEASE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DEGRADATION; TISSUE INJURY;

ALPHA 1-ANTITRYPSIN; COMPARATIVE STUDY; FIBRONECTINS; HUMAN; IN VITRO; LEUKOCYTE ELASTASE; LEUKOCYTES; OLIGOPEPTIDES; PANCREATIC ELASTASE; RECOMBINANT PROTEINS; SERINE PROTEINASE INHIBITORS; SUPPORT, NON-U.S. GOV'T;

EID: 0028298695     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.49.6.567     Document Type: Article

References (0)